September 18th 2024
The FDA has approved the Eversense 365, the world’s first 1-year continuous glucose monitor, with US availability expected in late 2024.
Hypertension has long been linked to obesity, but a new study shows that where that fat is matters. A team of researchers at University of Texas Southwestern Medical Center in Dallas, TX conclude that when that fat is in the viscera-as opposed to accumulating under the skin-there is a strong chance patients will develop hypertension.
Model Helps Predict Patient Risk for Major Type 1 Diabetes Complications
Patients diagnosed with type 1 diabetes are at higher risk for developing major health complications but up until now there had been no reliable way to determine which complications a patient might develop or how severe they might be.
VBLOCK Shows Success with Diabetes, Hypertension and Weight Loss
A 3-year study of a product meant to help patients dealing with a wide range of conditions including diabetes, hypertension, and weight loss showed positive results according to manufacturer EnteroMedics, Inc.
Poor Understanding of Gastroparesis Detrimental to Patients
Gastroparesis, or delayed gastric emptying, remains misunderstood despite rising prevalence, according to a news release from the International Foundation for Functional Gastrointestinal Disorders (IFFGD), a nonprofit research and education organization addressing issues surrounding gastrointestinal and motility disorders.
The Brain-Centered Glucoregulatory System: 4 Important New Studies
August 21st 2014If the BCGS model is accurate, brain and periphery communicate continuously about glucose homeostasis and a change in the brain can alter insulin sensitivity in the periphery. Read this review, and you'll be up-to-date.